Buy Eli Lilly on 'new products story,' shares to rally 20%, Goldman says
September 27, 2016 at 09:27 AM EDT
Lilly is "a compelling new products story with multiple assets," Goldman Sachs says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.